Lantheus VP to Discuss External Manufacturing at Goldman Sachs Healthcare Conference
Event summary
- Lantheus VP John Wiggins to participate in fireside chat at Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
- Webcast available live and for 30 days post-event on Lantheus website.
- Lantheus operates in radiopharmaceuticals with global presence across 6 countries.
The big picture
Lantheus' participation in the Goldman Sachs conference underscores its strategic focus on external manufacturing, a critical component in the radiopharmaceutical supply chain. The event provides a platform to discuss operational efficiencies and market positioning amidst increasing demand for advanced diagnostic and therapeutic solutions. With a 70-year history, Lantheus is well-positioned to capitalize on trends in precision medicine and targeted therapies.
What we're watching
- Strategic Positioning
- How Lantheus will leverage this platform to highlight its external manufacturing capabilities and competitive advantages.
- Industry Trends
- Whether the focus on radiopharmaceuticals aligns with broader healthcare sector shifts towards precision medicine.
- Execution Risk
- The pace at which Lantheus can scale its operations to meet growing demand in the radiopharmaceutical market.
Related topics